Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

The Arsenal veteran emerges as a surprise option for Barcelona next summer

Barcelona’s sporting directors spend a lot more time analyzing the free agent market these days compared to a decade ago, and one of the players out of contract next summer whose name has been marked in red is Arsenal midfielder Thomas Partey. The 31-year-old made his breakthrough with Atletico Madrid before moving to London.

According to MD, Partey is one of several players that Barcelona is considering as free transfer options. Others such as Jonathan Tah and Jonathan David are better documented, but the Ghanaian midfielder would be a potential alternative to join for free next summer if Frenkie de Jong leaves. The Blaugrana predict they will put De Jong up for sale next summer, which is dependent on him signing a new contract. Partey would fit some of the characteristics listed by Deco: experienced, physically imposing and versatile. The Portuguese has been an admirer of Partey for a long time.

The Ghana international remains an important part of Mikel Arteta’s Arsenal operations, having started 14 of their 18 Premier League games this season, and all six in the Champions League, missing one through injury. Partey is certainly a more imposing option than most of Barcelona’s options and, apart from Marc Casado, is by far the most defensive option that Hansi Flick can use.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.